Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Yunnan Kingtide Notoginseng Industry is a specialized pharmaceutical and health products company based in Wenshan, China, focusing on the cultivation, processing, and research of Panax notoginseng (Sanqi). The company operates a full industrial chain, from standardized GAP planting to the production of traditional Chinese medicine (TCM) extracts, health supplements, and finished pharmaceutical products. Its core offerings include notoginseng saponins and various formulations aimed at treating cardiovascular and cerebrovascular diseases. Kingtide is recognized for its high-quality standards in the TCM industry and its efforts to modernize traditional herbal medicine through scientific R&D.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Kingtide Notoginseng Industry.